Advertisement
Screener

Organon & Co. (OGN) ROE

Organon & Co. (OGN) ROE

  • 2026-06-30: ROE 20.78%.
  • 2026-03-31: ROE 27.24%.
  • 2025-12-31: ROE 24.87%.
  • 2025-09-30: ROE 55.30%.

Complete source-backed roe history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-3020.78%
2026-03-3127.24%
2025-12-3124.87%
2025-09-3055.30%
2025-06-3095.50%
2025-03-31138.38%
2024-12-31183.05%
2024-09-30263.89%
2024-06-30694.44%
2024-03-312181.25%
2023-12-31-1461.43%
2023-09-30-99.32%
2023-06-30-135.86%
2023-03-31-101.22%
2022-12-31-102.80%
2022-09-30-94.84%
2022-06-30-97.36%
2022-03-31-104.00%
2021-12-31-89.59%
2021-09-30-93.76%
2021-06-30-90.02%
2021-03-3139.31%
2020-12-3139.37%

Annual ROE

DateROE
2025-12-3124.87%
2024-12-31183.05%
2023-12-31-1461.43%
2022-12-31-102.80%
2021-12-31-89.59%
2020-12-3139.37%
2019-12-3145.74%

Similar stocks

Stock NameCountryMarket CapPE Ratio
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53